We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Oxford Biomedica Plc | LSE:OXB | London | Ordinary Share | GB00BDFBVT43 | ORD 50P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 276.50 | 272.00 | 276.50 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Medicinal Chems,botanicl Pds | 139.99M | -45.16M | -0.4676 | -5.91 | 267.05M |
TIDMOXB TIDMPRU
RNS Number : 3766V
Oxford Biomedica PLC
06 August 2015
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) ---------------------------------------------------------------------------------------------- 1. Identity of the issuer or Oxford Biomedica Plc the underlying issuer of existing shares to which voting rights are attached: (ii) ---------------------------------------------------------- ---------------------------------- 2 Reason for the notification (please tick the appropriate box or boxes): ---------------------------------------------------------------------------------------------- An acquisition or disposal of voting rights X ---------------------------------------------------------- ---------------------------------- An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached ---------------------------------------------------------- ---------------------------------- An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments ---------------------------------------------------------- ---------------------------------- An event changing the breakdown of voting rights ---------------------------------------------------------- ---------------------------------- Other (please specify): ---------------------------------------------------------- ---------------------------------- 3. Full name of person(s) Prudential plc group of companies subject to the notification obligation: (iii) ---------------------------------------------------------- ---------------------------------- 4. Full name of shareholder(s) (if different from 3.):(iv) Prudential plc M&G Group Limited M&G Limited M&G Investment Management Limited M&G Securities Limited ---------------------------------------------------------- ---------------------------------- 5. Date of the transaction 05 August 2015 and date on which the threshold is crossed or reached: (v) ---------------------------------------------------------- ---------------------------------- 6. Date on which issuer 06 August 2015 notified: ---------------------------------------------------------- ---------------------------------- 7. Threshold(s) that is/are crossed or reached: (vi, vii) 18% - 17% ---------------------------------------------------------- ---------------------------------- 8. Notified details: ---------------------------------------------------------------------------------------------------------------------------------- A: Voting rights attached to shares (viii, ix) ---------------------------------------------------------------------------------------------------------------------------------- Class/type Situation previous Resulting situation after the of to the triggering triggering transaction shares transaction if possible using the ISIN CODE ------------- ----------------------------------------------- ------------------------------------------------------------------ Number Number Number Number of % of voting of of of shares voting rights (x) Shares Voting rights Rights ------------- ---------------- ----------------------------- -------------- ------------------------- ----------------------- Direct Direct Indirect Direct Indirect (xi) (xii) ------------- ------------ ----------- ------------ -------------- -------------- --------- ---------- ----------- GB0006648157 463,083,605 463,083,605 462,983,605 462,983,605 0 17.99% 0 ------------- ---------------- ----------------------------- -------------- -------------- --------- ---------- ----------- B: Qualifying Financial Instruments ---------------------------------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ---------------------------------------------------------------------------------------------------------------------------------- Type of Expiration Exercise/ Number of voting % of voting financial date Conversion rights that rights instrument (xiii) Period (xiv) may be acquired if the instrument is exercised/ converted. ----------------- ---------------- ------------------------------------------- ------------------------- --------------------- C: Financial Instruments with similar economic effect to Qualifying Financial Instruments (xv, xvi) ---------------------------------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ---------------------------------------------------------------------------------------------------------------------------------- Type of Exercise Expiration Exercise/ Number of voting % of voting financial price date Conversion rights instrument rights (xix, instrument (xvii) period refers to xx) (xviii) --------------- ---------------- ------------- -------------- --------------------------------------- ----------------------- Nominal Delta --------------- ---------------- ------------- -------------- --------------------------------------- ------------ --------- Total (A+B+C) ---------------------------------------------------------------------------------------------------------------------------------- Number of voting rights Percentage of voting rights ---------------------------------------------------------------- ---------------------------------------------------------------- 462,983,605 17.99% ---------------------------------------------------------------- ---------------------------------------------------------------- 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: (xxi) -------------------------------------------------------------------------------------- Prudential plc (parent Company) - 462,983,605 (17.99%) M&G Group Limited (wholly owned subsidiary of Prudential plc) - 462,983,605 (17.99%) M&G Limited (wholly owned subsidiary of M&G Group Limited) - 462,983,605 (17.99%) M&G Investment Management Limited (wholly owned subsidiary of M&G Limited) - 462,983,605 (17.99%) M&G Securities Limited (wholly owned subsidiary of M&G Limited) - 439,485,985 (17.08%) Proxy Voting: -------------------------------------------------------------------------------------- 10. Name of the proxy holder: N/A -------------------------------------------------------- ---------------------------- 11. Number of voting rights proxy N/A holder will cease to hold: -------------------------------------------------------- ---------------------------- 12. Date on which proxy holder will N/A cease to hold voting rights: -------------------------------------------------------- ---------------------------- 13. Additional information: -------------------------------------------------------- ---------------------------- 14. Contact name: Tim Watts, Oxford BioMedica PLC -------------------------------------------------------- ---------------------------- 15. Contact telephone number: 01865 783000 -------------------------------------------------------- ----------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUNANRVVAWRAR
1 Year Oxford Biomedica Chart |
1 Month Oxford Biomedica Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions